BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 18067646)

  • 21. Clinical and serological study of the human immunodeficiency virus infection in a cohort of multitransfused persons.
    Mokhbat JE; Naman RE; Rahme FS; Farah AE; Zahar KL; Maalouf A
    J Med Liban; 1989; 38(1):9-14. PubMed ID: 2519339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dr. P. C. Sen Memorial Award Paper. A study of HIV infection in thalassaemia patients of rural Bengal.
    Sur D; Chakraborty AK; Mukhopadhyay SP
    Indian J Public Health; 1998; 42(3):81-7. PubMed ID: 10389518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Consideration in hemophilia therapy selection.
    Pipe S
    Semin Hematol; 2006 Apr; 43(2 Suppl 3):S23-7. PubMed ID: 16631824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Residual infectious disease risk in screened blood transfusion from a high-prevalence population: Santa Catarina, Brazil.
    Maresch C; Schluter PJ; Wilson AD; Sleigh A
    Transfusion; 2008 Feb; 48(2):273-81. PubMed ID: 18005323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C virus genotypes among patients with thalassemia and inherited bleeding disorders in Markazi province, Iran.
    Samimi-Rad K; Shahbaz B
    Haemophilia; 2007 Mar; 13(2):156-63. PubMed ID: 17286768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Communicable diseases in the immigrant population attended to in a tropical medicine unit: epidemiological aspects and public health issues.
    Manzardo C; Treviño B; Gómez i Prat J; Cabezos J; Monguí E; Clavería I; Luis Del Val J; Zabaleta E; Zarzuela F; Navarro R
    Travel Med Infect Dis; 2008; 6(1-2):4-11. PubMed ID: 18342267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transmission of infectious disease in the dental setting.
    Heir J; Ziccardi VB
    Mt Sinai J Med; 1998; 65(5-6):378-82. PubMed ID: 9844366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
    Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
    Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hepatitis A and hemophilia in Aragon, Spain].
    García Erce JA; Solano Bernad VM; Ferrer Torres J; Lucía Cuesta JF
    Sangre (Barc); 1997 Jun; 42(3):252-3. PubMed ID: 9381275
    [No Abstract]   [Full Text] [Related]  

  • 30. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiphospholipid antibodies and hepatitis C virus infection in Iranian thalassemia major patients.
    Kashef S; Karimi M; Amirghofran Z; Ayatollahi M; Pasalar M; Ghaedian MM; Kashef MA
    Int J Lab Hematol; 2008 Feb; 30(1):11-6. PubMed ID: 18190462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modelling infectious disease transmission with complex exposure pattern and sparse outcome data.
    Reilly M; Salim A; Lawlor E; Smith O; Temperley I; Pawitan Y
    Stat Med; 2004 Oct; 23(19):3013-32. PubMed ID: 15351958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transfusion-transmitted infection in hemophilia in developing countries.
    Yee TT; Lee CA
    Semin Thromb Hemost; 2005 Nov; 31(5):527-37. PubMed ID: 16276461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Blood transfusion: control of infectious risks].
    Laperche S; Lefrère JJ; Morel P; Pouchol E; Pozzetto B
    Presse Med; 2015 Feb; 44(2):189-99. PubMed ID: 25547992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemophilia therapy and blood-borne pathogen risk.
    Knight R; Stanley S; Wong M; Dolan G
    Semin Thromb Hemost; 2006 Jun; 32 Suppl 2():3-9. PubMed ID: 16804829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcome of frequent exposure to Torque Teno virus (TTV) through blood transfusion in thalassemia patients with or without hepatitis C virus (HCV) infection.
    Hu YW; Al-Moslih MI; Al Ali MT; Uzicanin S; Perkins H; Yi QL; Rahimi Khameneh S; Wu J; Brown EG
    J Med Virol; 2008 Feb; 80(2):365-71. PubMed ID: 18098140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seroprevalence of HCV antibody among patients with beta-thalassemia major in Amirkola Thalassemia Center, Iran.
    Tamaddoni A; Mohammadzadeh I; Ziaei O
    Iran J Allergy Asthma Immunol; 2007 Mar; 6(1):41. PubMed ID: 17303929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The actual risk of retrovirus transmission from transfusions].
    Soriano V; Mas A
    Sangre (Barc); 1995 Oct; 40(5):407-16. PubMed ID: 8553176
    [No Abstract]   [Full Text] [Related]  

  • 39. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Routines ordered by law for testing of potential disease transmission are not sufficient].
    Andersen BM
    Tidsskr Nor Laegeforen; 1999 Jan; 119(2):252-3. PubMed ID: 10081361
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.